Log Type Authored on Log Message Log Node Authored by
User created User created Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter clicked Clicked https://japan.progress.im/ja/content/%E3%83%80%E3%82%A4%E3%83%A4%E3%83%A2%E3%83%B3%E3%83%89%E3%83%BB%E3%83%97%E3%83%AA%E3%83%B3%E3%82%BB%E3%82%B9%E5%8F%B7%E3%81%AE%E4%B9%97%E5%AE%A2%E3%83%BB%E4%B9%97%E5%93%A1%E5%8F%97%E3%81%91%E5%85%A5%E3%82%8C%E3%81 Anonymous
Newsletter opened Opened Anonymous
Newsletter clicked Clicked https://japan.progress.im/ja/content/%E5%91%A8%E7%94%A3%E6%9C%9F%E5%A5%B3%E6%80%A7%E3%81%A7%E3%81%AFcovid-19%E3%83%91%E3%83%B3%E3%83%87%E3%83%9F%E3%83%83%E3%82%AF%E7%B5%A1%E3%81%BF%E3%81%AE%E5%81%A5%E5%BA%B7%E4%B8%8A%E3%81%AE%E4%B8%8D%E5%AE%89%E3%82% Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
User created User created Anonymous
Newsletter subscribed Newsletter subscribed - Newsletter de Progress in Mind España Anonymous
User created User created Anonymous
Newsletter subscribed Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created User created Anonymous
Newsletter opened Opened Todos os Episódios Disponíveis - Novo tratamento para resposta insatisfatória a antidepressivos no TDM Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Melhorar os resultados na esquizofrenia - oportunidades no tratamento de longo prazo Anonymous
Log Type Authored on Log Message Log Node Authored by
User created User created Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter clicked Clicked https://japan.progress.im/ja/content/%E3%83%80%E3%82%A4%E3%83%A4%E3%83%A2%E3%83%B3%E3%83%89%E3%83%BB%E3%83%97%E3%83%AA%E3%83%B3%E3%82%BB%E3%82%B9%E5%8F%B7%E3%81%AE%E4%B9%97%E5%AE%A2%E3%83%BB%E4%B9%97%E5%93%A1%E5%8F%97%E3%81%91%E5%85%A5%E3%82%8C%E3%81 Anonymous
Newsletter opened Opened Anonymous
Newsletter clicked Clicked https://japan.progress.im/ja/content/%E5%91%A8%E7%94%A3%E6%9C%9F%E5%A5%B3%E6%80%A7%E3%81%A7%E3%81%AFcovid-19%E3%83%91%E3%83%B3%E3%83%87%E3%83%9F%E3%83%83%E3%82%AF%E7%B5%A1%E3%81%BF%E3%81%AE%E5%81%A5%E5%BA%B7%E4%B8%8A%E3%81%AE%E4%B8%8D%E5%AE%89%E3%82% Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Anonymous
User created User created Anonymous
Newsletter subscribed Newsletter subscribed - Newsletter de Progress in Mind España Anonymous
User created User created Anonymous
Newsletter subscribed Newsletter subscribed - Progress in Mind Brazil newsletter Anonymous
User created User created Anonymous
Newsletter opened Opened Todos os Episódios Disponíveis - Novo tratamento para resposta insatisfatória a antidepressivos no TDM Anonymous
Newsletter opened Opened Anonymous
Newsletter opened Opened Melhorar os resultados na esquizofrenia - oportunidades no tratamento de longo prazo Anonymous